日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

哪些 CD4 T 细胞计数高的 HIV 感染成人最能从立即开始抗逆转录病毒治疗中获益?START 试验的事后亚组分析

Molina Jean-Michel, Grund Birgit, Gordin Fred, Williams Ian, Schechter Mauro, Losso Marcello, Law Matthew, Ekong Ernest, Mwelase Noluthando, Skoutelis Athanasios, Wiselka Martin J, Vandekerckhove Linos, Benfield Thomas, Munroe David, Lundgren Jens D, Neaton James D

Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065)

为促进 HIV 感染者接受治疗和病毒抑制提供经济激励:一项随机临床试验 (HPTN 065)

El-Sadr, Wafaa M; Donnell, Deborah; Beauchamp, Geetha; Hall, H Irene; Torian, Lucia V; Zingman, Barry; Lum, Garret; Kharfen, Michael; Elion, Richard; Leider, Jason; Gordin, Fred M; Elharrar, Vanessa; Burns, David; Zerbe, Allison; Gamble, Theresa; Branson, Bernard

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

立即启动抗逆转录病毒疗法对CD4细胞计数超过500个/μL的HIV感染者发生严重细菌感染风险的影响:一项随机对照试验的次要结局结果

O'Connor, Jemma; Vjecha, Michael J; Phillips, Andrew N; Angus, Brian; Cooper, David; Grinsztejn, Beatriz; Lopardo, Gustavo; Das, Satyajit; Wood, Robin; Wilkin, Aimee; Klinker, Hartwig; Kantipong, Pacharee; Klingman, Karin L; Jilich, David; Herieka, Elbushra; Denning, Eileen; Abubakar, Ibrahim; Gordin, Fred; Lundgren, Jens D

Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials

经验教训:大型公共资助国际试验的基础设施建设和财务管理

Larson, Gregg S; Carey, Cate; Grarup, Jesper; Hudson, Fleur; Sachi, Karen; Vjecha, Michael J; Gordin, Fred

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

早期无症状HIV感染者开始抗逆转录病毒治疗

Lundgren, Jens D; Babiker, Abdel G; Gordin, Fred; Emery, Sean; Grund, Birgit; Sharma, Shweta; Avihingsanon, Anchalee; Cooper, David A; Fätkenheuer, Gerd; Llibre, Josep M; Molina, Jean-Michel; Munderi, Paula; Schechter, Mauro; Wood, Robin; Klingman, Karin L; Collins, Simon; Lane, H Clifford; Phillips, Andrew N; Neaton, James D

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

为何要启动这项大型长期战略性艾滋病试验?促使我们开展这项试验的思考历程

Lundgren, Jens; Babiker, Abdel; Gordin, Fred; Emery, Sean; Fätkenheuer, Gerd; Molina, Jean-Michel; Wood, Robin; Neaton, James D

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

何时开始抗逆转录病毒治疗:早期 HIV 感染期间需要循证依据

Lundgren, Jens D; Babiker, Abdel G; Gordin, Fred M; Borges, Álvaro H; Neaton, James D

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

抗逆转录病毒治疗策略时机(START)研究的理论依据、设计和方法中的考虑因素

Babiker, Abdel G; Emery, Sean; Fätkenheuer, Gerd; Gordin, Fred M; Grund, Birgit; Lundgren, Jens D; Neaton, James D; Pett, Sarah L; Phillips, Andrew; Touloumi, Giota; Vjechaj, Michael J

Current approaches to tuberculosis in the United States

美国目前应对结核病的方法

Gordin, Fred M; Masur, Henry

USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?

USA300 耐甲氧西林金黄色葡萄球菌菌血症与严重败血症风险:USA300 耐甲氧西林金黄色葡萄球菌是否与更严重的感染有关?

Kreisel, Kristen M; Stine, O Colin; Johnson, J Kristie; Perencevich, Eli N; Shardell, Michelle D; Lesse, Alan J; Gordin, Fred M; Climo, Michael W; Roghmann, Mary-Claire